Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2-E2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Department of Surgery and Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
World J Surg. 2020 Jul;44(7):2332-2339. doi: 10.1007/s00268-020-05486-2.
Laparoscopic gastrectomy (LG) is now practiced widely, but it is unclear whether LG is the appropriate approach for elderly patients with resectable advanced gastric cancer. The aim of this study was to examine whether LG is more or less advantageous for elderly patients than for young patients.
We collected data on 571 consecutive patients who underwent gastrectomy for pT2-4 gastric cancer between January 2001 and December 2015. After adjustment with one-to-one propensity score matching, short-term and long-term outcomes were compared between the LG and open gastrectomy (OG) groups among young (age < 70 years) and elderly (age ≥ 70 years) patients.
The LG group had a significantly longer operative time (P < 0.001) and less blood loss (P < 0.001) than the OG group among young and elderly patients. There were no significant differences regarding complications. Although disease-specific survival was similar between the LG and OG groups among young and elderly patients, LG was associated with more favorable overall survival than OG only among elderly patients (hazard ratio 0.67; 95% confidence interval 0.35-1.26). Death from respiratory diseases occurred more frequently in the OG group (10.9%) than in the LG group (0%) for elderly patients (P = 0.012).
LG for resectable advanced gastric cancer was not inferior to OG in terms of both short-term and long-term outcomes regardless of patient age. In elderly patients, LG may improve overall survival by reducing mortality from respiratory diseases.
腹腔镜胃切除术(LG)现在已广泛应用,但对于可切除的进展期胃癌老年患者,LG 是否为合适的治疗方法尚不清楚。本研究旨在探讨 LG 是否对老年患者比年轻患者更具优势。
我们收集了 2001 年 1 月至 2015 年 12 月期间接受胃切除术治疗 pT2-4 期胃癌的 571 例连续患者的数据。通过 1:1 倾向评分匹配调整后,比较了 LG 和开腹胃切除术(OG)组在年轻(年龄<70 岁)和老年(年龄≥70 岁)患者中的短期和长期结果。
LG 组在年轻和老年患者中的手术时间(P<0.001)和出血量(P<0.001)均显著长于 OG 组。两组并发症无显著差异。尽管 LG 和 OG 两组在年轻和老年患者中的疾病特异性生存率相似,但 LG 与 OG 相比,仅在老年患者中具有更好的总生存率(风险比 0.67;95%置信区间 0.35-1.26)。老年患者 OG 组(10.9%)的呼吸系统疾病死亡率高于 LG 组(0%)(P=0.012)。
对于可切除的进展期胃癌,无论患者年龄如何,LG 在短期和长期结果方面均不劣于 OG。在老年患者中,LG 可能通过降低呼吸系统疾病死亡率来改善总生存率。